Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial
卡瑞利珠单抗联合化疗治疗复发或转移性鼻咽癌的五年疗效:CAPTAIN-1st随机临床试验的二次分析
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2025.6245
Huang, Yan; Sun, Dongchen; Zhou, Huaqiang; Zhou, Ting; Qu, Song; Li, Jingao; Hu, Chaosu; Xu, Mingjun; Li, Weidong; Shen, Liangfang; Wu, Hui; Lang, Jinyi; Hu, Guangyuan; Luo, Zhanxiong; Fu, Zhichao; Qu, Shenhong; Feng, Weineng; Chen, Xiaozhong; Lin, Shaojun; Xie, Bo; Li, Xiaojiang; Sun, Yan; Lin, Zhixiong; Lin, Qin; Lei, Feng; Long, Jianting; Hong, Jinsheng; Huang, Xiaoming; Zeng, Lingzhi; Wang, Peiguo; He, Xiaohui; Zhao, Shen; Chen, Gang; Zhang, Yaxiong; Zhao, Yuanyuan; Fang, Wenfeng; Huang, Chuanpei; Li, Xiaotong; Hong, Shaodong; Zhang, Li; Yang, Yunpeng